TIAN RUIXIANG Holdings to Acquire Ucare Inc. in $150 Million Deal

Tian Ruixiang Holdings ( (TIRX) ) has shared an update.

On May 30, 2025, TIAN RUIXIANG Holdings Ltd announced a strategic acquisition of Ucare Inc. in an all-stock deal valued at US$150 million. Ucare, known for its cloud-based AI-driven hospital and health insurance risk management platform, will become a wholly-owned subsidiary of TRX’s VitaCare Limited. This acquisition aims to enhance TRX’s health insurance offerings and leverage Ucare’s AI capabilities to improve healthcare access and reduce costs. The transaction, expected to close in July 2025, will see Ucare’s shares held in escrow and released based on performance targets. This move positions TRX to capitalize on the expanding health insurance market in China, aligning with national health coverage reforms.

Spark’s Take on TIRX Stock

According to Spark, TipRanks’ AI Analyst, TIRX is a Neutral.

The overall score is primarily influenced by the company’s financial challenges, despite a strong balance sheet. The technical indicators suggest positive short-term momentum, but the negative valuation metrics reflect significant risks. Addressing profitability issues could improve the outlook.

To see Spark’s full report on TIRX stock, click here.

More about Tian Ruixiang Holdings

TIAN RUIXIANG Holdings Ltd, headquartered in Beijing, China, is an insurance broker that operates through its China-based variable interest entity. The company distributes a wide range of insurance products, including property and casualty insurance such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance, as well as health insurance, life insurance, and other miscellaneous insurance.

Average Trading Volume: 50,803

Technical Sentiment Signal: Sell

Current Market Cap: $18.61M

See more insights into TIRX stock on TipRanks’ Stock Analysis page.